5-Fluorouracil-related enhancement of adenoviral infection in Coxsackievirus-Adenovirus receptor independent and associated with morphological changes in lipid membranes

World Journal of Gastroenterology

Volumn 12, Issue 32, 2006, Pages 5168-5174

  Cabrele, Chiara ^a   Vogel, Mandy ^a   Piso, Pompiliu ^a   Rentsch, Markus ^a   Schröder, Josef ^a   Jauch, Karl W ^a   Schlitt, Hans J ^a   Beham, Alexander ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

5 Fluorouracil; Adenoviral infection; Coxsacklevirus Adenovirus receptor; Gene therapy

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; FLUOROURACIL; GLYCOPROTEIN E1; GREEN FLUORESCENT PROTEIN; LIPOSOME; PROTEIN BAX;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEK293; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOMEGALOVIRUS; ELECTRON MICROSCOPY; ENCAPSULATION; GENE DELETION; GENE THERAPY; HUMAN; HUMAN CELL; LIPID MEMBRANE; MEDICAL DECISION MAKING; MORPHOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SUPERNATANT; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION;

EID: 33748507801     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323
2. Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, Wang Z, Hsieh JT. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999; 59: 325-330
3. Pearson AS, Koch PE, Atkinson N, Xiong M, Finberg RW, Roth JA, Fang B. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines. Clin Cancer Res 1999; 5: 4208-4013
4. Li D, Duan L, Freimuth P, O'Malley BW Jr. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 1999; 5: 4175-4181
5. Okegawa T, Li Y, Pong RC, Bergelson JM, Zhou J, Hsieh JT. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 2000; 60: 5031-5036
6. Reid T, Galanis E, Abbruzzese J, Sze D, Andrews J, Romel L, Hatfield M, Rubin J, Kirn D. Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Ther 2001; 8: 1618-1626
7. Petit T, Davidson KK, Cerna C, Lawrence RA, Von Hoff DD, Heise C, Kirn D, Izbicka E. Efficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 status. Anticancer Drugs 2002; 13: 47-50
8. Heise C, Lemmon M, Kirn D. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration. Clin Cancer Res 2000; 6: 4908-4914
9. Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK, Kirn DH. a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000; 6: 879-885
10. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514
11. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology 1992; 20: 363-390
12. Mann J. Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2002; 2: 143-148
13. Lasch J, Hoffmann J, Omelyanenko WG, Klibanov AA, Torchilin VP, Binder H, Gawrisch K. Interaction of Triton X-100 and octyl glucoside with liposomal membranes at sublytic and lytic concentrations. Spectroscopic studies. Biochim Biophys Acta 1990; 1022: 171-180
14. Sanchez-Prieto R, Quintanilla M, Cano A, Leonart ML, Martin P, Anaya A, Ramon y Cajal S. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene. Oncogene 1996; 13: 1083-1092
15. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, Kelso GF, Smith RA, Kinzler KW, Vogelstein B. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 2001; 7: 1111-1117
16. Nemerow GR, Stewart PL. Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 1999; 63: 725-734
17. Shiao YJ, Chen JC, Wang CT. The solubilization and morphological change of human platelets in various detergents. Biochim Biophys Acta 1989; 980: 56-68
18. Habib NA, Mitry RR, Sarraf CE, Jiao LR, Havlik R, Nicholls J, Jensen SL. Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with d11520 adenovirus. Cancer Gene Ther 2002; 9: 414-420
19. Boffi F, Caminiti R, Sadun C, Capuani S, Giovanelli A, Congiu Castellano A. A structural and kinetic study by energy dispersion X-ray diffraction: interaction between 1,4-dihydropyridines and biological membranes. Chem Phys Lett 1998; 286: 473-478
20. Pinto LM, Yokaichiya DK, Fraceto LF, de Paula E. Interaction of benzocaine with model membranes. Biophys Chem 2000; 87: 213-223
21. Hirata K, Horie T. Changes in intestinal absorption of 5-fluorouracil-treated rats. Pharmacol Toxicol 1999; 85: 33-36